Mike Wang

2.2k total citations · 1 hit paper
31 papers, 1.0k citations indexed

About

Mike Wang is a scholar working on Molecular Biology, Electrical and Electronic Engineering and Oncology. According to data from OpenAlex, Mike Wang has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Electrical and Electronic Engineering and 6 papers in Oncology. Recurrent topics in Mike Wang's work include Cancer Immunotherapy and Biomarkers (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Mike Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Mike Wang collaborates with scholars based in United States, Canada and Taiwan. Mike Wang's co-authors include Jordan Peccia, Alessandro Zulli, Edward H. Kaplan, Amyn A. Malik, Dennis Wang, Daniel M. Weinberger, Arnau Casanovas‐Massana, Doug E. Brackney, Nathan D. Grubaugh and Albert I. Ko and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Mike Wang

28 papers receiving 1.0k citations

Hit Papers

Measurement of SARS-CoV-2 RNA in wastewater tracks commun... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Wang United States 11 629 354 262 120 68 31 1.0k
Alexander Bello Canada 7 664 1.1× 178 0.5× 172 0.7× 76 0.6× 85 1.3× 8 922
Xiujuan Qu China 10 890 1.4× 148 0.4× 250 1.0× 124 1.0× 82 1.2× 17 1.3k
Tianhao Sun China 15 404 0.6× 72 0.2× 266 1.0× 55 0.5× 37 0.5× 28 924
Kaisong Wu China 6 494 0.8× 103 0.3× 95 0.4× 79 0.7× 45 0.7× 16 760
Hannah M. Thompson United States 13 401 0.6× 254 0.7× 90 0.3× 88 0.7× 21 0.3× 34 817
Zhanlian Huang China 12 498 0.8× 52 0.1× 96 0.4× 74 0.6× 68 1.0× 26 894
Jin Chen China 16 311 0.5× 30 0.1× 317 1.2× 89 0.7× 18 0.3× 70 1.1k
Lan Yang China 12 819 1.3× 61 0.2× 199 0.8× 24 0.2× 12 0.2× 22 1.3k

Countries citing papers authored by Mike Wang

Since Specialization
Citations

This map shows the geographic impact of Mike Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Wang more than expected).

Fields of papers citing papers by Mike Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Wang. The network helps show where Mike Wang may publish in the future.

Co-authorship network of co-authors of Mike Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Wang. A scholar is included among the top collaborators of Mike Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Wang. Mike Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chewcharat, Api, et al.. (2025). Eculizumab Prophylaxis for Systematic Rechallenging Gemcitabine in Gemcitabine-Induced Thrombotic Microangiopathy: A Case Report. American Journal of Kidney Diseases. 86(5). 710–714.
2.
Durbin, Sienna, Chia‐Yun Wu, Jaclyn LoPiccolo, et al.. (2025). Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy. JAMA Network Open. 8(3). e252668–e252668. 10 indexed citations
3.
Wang, Mike, Ryan J. Sullivan, & Meghan J. Mooradian. (2024). Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success. Current Oncology Reports. 26(8). 934–944. 1 indexed citations
4.
Wang, Mike, et al.. (2023). Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clinical Gastroenterology and Hepatology. 22(7). 1539–1541.e2. 8 indexed citations
6.
Mittal, Amit, Mike Wang, Aurobind Vidyarthi, et al.. (2021). Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma. Scientific Reports. 11(1). 10731–10731. 12 indexed citations
7.
Nouri, Mannan, Josselin Caradec, Amy A. Lubik, et al.. (2020). Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer. Clinical Cancer Research. 26(7). 1678–1689. 29 indexed citations
8.
Kaplan, Edward H., Dennis Wang, Mike Wang, et al.. (2020). Aligning SARS-CoV-2 indicators via an epidemic model: application to hospital admissions and RNA detection in sewage sludge. Health Care Management Science. 24(2). 320–329. 47 indexed citations
9.
Peccia, Jordan, Alessandro Zulli, Doug E. Brackney, et al.. (2020). Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics. Nature Biotechnology. 38(10). 1164–1167. 640 indexed citations breakdown →
10.
Jiang, Xiaodong, Mike Wang, Nika Cyrus, et al.. (2019). Human keratinocyte carcinomas have distinct differences in their tumor-associated macrophages. Heliyon. 5(8). e02273–e02273. 10 indexed citations
11.
Wang, Mike & Oscar R. Colegio. (2019). Nail changes, lymphedema, and respiratory symptoms. JAAD Case Reports. 5(9). 773–775. 4 indexed citations
12.
Wang, Mike, Nour Kibbi, Nan Ring, et al.. (2019). DUSP22-IRF4 rearrangement in AIDS-associated ALK-negative anaplastic large cell lymphoma. BMJ Case Reports. 12(9). e230641–e230641. 2 indexed citations
13.
Wang, Mike, et al.. (2019). The Nurse's Guide to Innovation: Accelerating the Journey. 1 indexed citations
14.
Wiznia, Daniel H., Mike Wang, Chang-Yeon Kim, & Michael Leslie. (2018). The Effect of Insurance Type on Patient Access to Ankle Fracture Care Under the Affordable Care Act. PubMed. 47(9). 6 indexed citations
15.
Buckner, Tyler W., Andrew D. Leavitt, Margaret V. Ragni, et al.. (2016). Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thrombosis and Haemostasis. 116(7). 42–49. 28 indexed citations
16.
Lemire, Mathieu, Maria Ban, Bing Ge, et al.. (2015). Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent loci. Nature Communications. 6(1). 6326–6326. 90 indexed citations
17.
Wang, Mike, John H. Zhang, & Richard L. Applegate. (2014). Adverse effect of inhalational anesthetics on the developing brain. Medical Gas Research. 4(1). 2–2. 12 indexed citations
18.
Iskedjian, Michaël, et al.. (2010). Methylnaltrexone in the Treatment of Opioid-Induced Constipation in Cancer Patients Receiving Palliative Care: Willingness-to-Pay and Cost-Benefit Analysis. Journal of Pain and Symptom Management. 41(1). 104–115. 13 indexed citations
19.
Harezlak, Jaroslaw, Mike Wang, David C. Christiani, & Xihong Lin. (2007). Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments. Bioinformatics. 23(18). 2441–2448. 9 indexed citations
20.
Dang, Louis T., Keejung Yoon, Mike Wang, & Nicholas Gaiano. (2006). Notch3 Signaling Promotes Radial Glial/Progenitor Character in the Mammalian Telencephalon. Developmental Neuroscience. 28(1-2). 58–69. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026